Order Article Reprints

Métivier C, Le Saëc P, Gaschet J, Chauvet C, Marionneau-Lambot S, Hofgaard PO, Bogen B, Pineau J, Le Bris N, Tripier R, et al. Preclinical Evaluation of a ⁶⁴Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma. Pharmaceutics. 2023; 15(7):1817. https://doi.org/10.3390/pharmaceutics15071817

Métivier, Cassandra, Patricia Le Saëc, Joëlle Gaschet, Catherine Chauvet, Séverine Marionneau-Lambot, Peter O. Hofgaard, Bjarne Bogen, Julie Pineau, Nathalie Le Bris, Raphaël Tripier, and et al. 2023. "Preclinical Evaluation of a ⁶⁴Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma" Pharmaceutics 15, no. 7: 1817. https://doi.org/10.3390/pharmaceutics15071817

Métivier, C., Le Saëc, P., Gaschet, J., Chauvet, C., Marionneau-Lambot, S., Hofgaard, P. O., Bogen, B., Pineau, J., Le Bris, N., Tripier, R., Alliot, C., Haddad, F., Chérel, M., Chouin, N., Faivre-Chauvet, A., & Rbah-Vidal, L. (2023). Preclinical Evaluation of a ⁶⁴Cu-Based Theranostic Approach in a Murine Model of Multiple Myeloma. Pharmaceutics, 15(7), 1817. https://doi.org/10.3390/pharmaceutics15071817